Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
Clinical trial NCT04091217 · COMPLETED
Trial details
- NCT number
- NCT04091217
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2022-08-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.